Abstract：Objective We obtained risk score through survival analysis of non-small-cell lung cancer surgery patients, and grouped death risk and discriminated patients with different death risk, so as to provide information to improve postoperative survival of patients. Methods We collected non-small-cell lung cancer medical records and follow-up data, and used Cox proportional hazards model for multivariate analysis, with the final model including factors with P＜0.10. The risk score was designed from coefficients of the significant factor1 and patients were divided into different groups according to their total score. Survival curves were estimated using Kaplan-Meier method. Results We collected 660 consecutive medical records and follow-up data in 5 years, and the overall 5-year survival rate was 55%. The final Cox regression model included age, tumor size, pathological types, pathological stage and systematic nodal dissection. Patients were grouped into low, medium, high and very high risk groups according to the risk scores. Five-year survival rates of the four groups were 66.4% in the low risk group, 53.4%(OR=1.72) in the medium group, 43.8%(OR=2.53) in the high risk group and 19.2%(OR=8.29) in the very high risk group respectively, and the difference was statistically significant different when the low risk group was compared with the other three groups. Conclusion We conducted survival analysis of non-small-cell lung cancer surgery patients and divided patients into different groups according to death risk scores, so as to differentiate patients of different death risks effectively. According to death risk groups, we can provide information for clinic for developing postoperative treatment, preventing postoperative death, and improving survival of non-small-cell lung cancer surgery patients.
蒋皓, 王心雨, 苏少飞, 张美奇, 王佳莹, 李习, 刘美娜. 非小细胞肺癌病人术后生存分析的死亡风险分组研究[J]. 中国医院统计, 2017, 24(3): 161-163.
Jiang Hao, Wang Xinyu, Su Shaofei, Zhang Meiqi, Wang Jiaying, Li Xi, Liu Meina. Risk grouping after survival analysis of non-small-cell lung cancer surgery patients. journal1, 2017, 24(3): 161-163.
[1] SCULIER JP, CHANSKY K, CROWLEY JJ, et al. The Impact of Additional Prognostic Factors on Survival and their Relationship with the Anatomical Extent of Disease Expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the Proposals for the 7th Edition[J]. Journal of Thoracic Oncology, 2008,3(5):457-466. [2] 刘桂芹.谈医院统计数据质量[J].中国医院统计,2012,19(1):55-57. [3] 王颖.病案统计工作与质量管理的分析[J].中国医院统计,2009,16(4):377-378. [4] DARLING GE, ALLEN MS, DECKER PA, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial[J]. Journal of Thoracic & Cardiovascular Surgery, 2011, 141(3):662-670. [5] WU YL, HUANG ZF, WANG SY, et al. A randomized trial of systemic nodal dissection in resectable non-small cell lung cancer[J]. Lung Cancer, 2002,36(1):1-6. [6] 李晓明,黄云超,陈安宁,等.系统性淋巴结清扫在非小细胞肺癌手术中的应用[J].昆明医科大学学报, 2007,28(6):103-105. [7] LIU T, LIU H, LI Y. Systematic lymph node dissection is necessary for T1a non-small cell lung cancer[J]. Asia-Pacific Journal of Clinical Oncology, 2014,11(1):49. [8] ASAMURA H, GOYA T, KOSHIISHI Y, et al. A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers[J]. Journal of Thoracic Oncology, 2008,48(4):333-344. [9] Paleari L, Russo P, Cesario A, et al. Factors predicting poor survival after resection of stage IA non-small cell lung cancer[J]. Journal of Thoracic & Cardiovascular Surgery, 2007,134(4):850-856.
